Glucose correlation with light scattering patterns--a novel method for non-invasive glucose measurements.

To correlate occlusion red near-infrared spectroscopy technology with intravenous and interstitial glucose levels, occlusion red near-infrared spectroscopy and glucose levels were measured in five subjects with diabetes mellitus during a stepped hyperinsulinemic hypoglycemic clamp. Validation was achieved using a standard error grid and linear correlations. During hyperinsulinemic hypoglycemic clamp linear correlation was significant at r = 0.836, and the intercept was 43.3 mg/dL. Of the glucose measurements, 94.3% were assigned to zones A and B of the standard error grid, the zones of the greatest therapeutic relevance. Expected interference from serum triglycerides, catecholamines, and cortisol was not apparent. These results demonstrate the applicability of occlusion red near-infrared spectroscopy for in vivo glucose monitoring. The technology has implications for continuous non-invasive glucose sensing.

[1]  P. Cryer Hypoglycemia is the limiting factor in the management of diabetes , 1999, Diabetes/metabolism research and reviews.

[2]  J F Stoltz,et al.  Erythrocyte aggregation: experimental approaches and clinical implications. , 1987, International angiology : a journal of the International Union of Angiology.

[3]  Kevin H. Hazen,et al.  Comparison of glucose concentration in interstitial fluid, and capillary and venous blood during rapid changes in blood glucose levels. , 2001, Diabetes technology & therapeutics.

[4]  Ilya Fine,et al.  Light-scattering changes caused by RBC aggregation: physical basis for new approach to noninvasive blood count , 2001, SPIE BiOS.

[5]  K. Jungheim,et al.  Glucose monitoring at the arm: risky delays of hypoglycemia and hyperglycemia detection. , 2002, Diabetes care.

[6]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[7]  O. Khalil,et al.  Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. , 2004, Diabetes technology & therapeutics.

[8]  L. D. Shvartsman,et al.  RBC-aggregation-assisted light transmission through blood and occlusion oximetry , 2000, European Conference on Biomedical Optics.

[9]  I. Shapira,et al.  Rheological determinants of red blood cell aggregation in diabetic patients in relation to their metabolic control , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[10]  R. Lasker,et al.  The diabetes control and complications trial. Implications for policy and practice. , 1993, The New England journal of medicine.